Revance Therapeutics, Inc. SEC Filings https://investors.revance.com/ Revance Therapeutics, Inc. SEC Filings en CT ORDER: CT ORDER https://investors.revance.com/sec-filings/sec-filing/ct-order/9999999997-19-004527 REVANCE THERAPEUTICS, INC. Fri, 17 May 2019 09:49:22 -0400 Revance Therapeutics, Inc. SEC Filings 10566 4: Statement of changes in beneficial ownership of securities https://investors.revance.com/sec-filings/sec-filing/4/0001479290-19-000062 REVANCE THERAPEUTICS, INC. Fri, 10 May 2019 21:13:49 -0400 Revance Therapeutics, Inc. SEC Filings 10546 4: Statement of changes in beneficial ownership of securities https://investors.revance.com/sec-filings/sec-filing/4/0001479290-19-000060 REVANCE THERAPEUTICS, INC. Fri, 10 May 2019 21:11:49 -0400 Revance Therapeutics, Inc. SEC Filings 10541 4: Statement of changes in beneficial ownership of securities https://investors.revance.com/sec-filings/sec-filing/4/0001479290-19-000058 REVANCE THERAPEUTICS, INC. Fri, 10 May 2019 21:07:49 -0400 Revance Therapeutics, Inc. SEC Filings 10536 4: Statement of changes in beneficial ownership of securities https://investors.revance.com/sec-filings/sec-filing/4/0001479290-19-000056 REVANCE THERAPEUTICS, INC. Fri, 10 May 2019 20:57:48 -0400 Revance Therapeutics, Inc. SEC Filings 10531 4: Statement of changes in beneficial ownership of securities https://investors.revance.com/sec-filings/sec-filing/4/0001479290-19-000054 REVANCE THERAPEUTICS, INC. Fri, 10 May 2019 20:55:48 -0400 Revance Therapeutics, Inc. SEC Filings 10526 4: Statement of changes in beneficial ownership of securities https://investors.revance.com/sec-filings/sec-filing/4/0001479290-19-000052 REVANCE THERAPEUTICS, INC. Fri, 10 May 2019 20:53:48 -0400 Revance Therapeutics, Inc. SEC Filings 10521 10-Q: Quarterly report which provides a continuing view of a company's financial position https://investors.revance.com/sec-filings/sec-filing/10-q/0001479290-19-000050 REVANCE THERAPEUTICS, INC. Thu, 09 May 2019 16:11:00 -0400 Revance Therapeutics, Inc. SEC Filings 10516 8-K: Report of unscheduled material events or corporate event https://investors.revance.com/sec-filings/sec-filing/8-k/0001479290-19-000046 REVANCE THERAPEUTICS, INC. Wed, 08 May 2019 16:11:05 -0400 Revance Therapeutics, Inc. SEC Filings 10511 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") https://investors.revance.com/sec-filings/sec-filing/def-14a/0001479290-19-000041 REVANCE THERAPEUTICS, INC. Mon, 25 Mar 2019 16:31:59 -0400 Revance Therapeutics, Inc. SEC Filings 10461